1208O - Phase 2 study of ceritinib in ALKi-naïve patients (pts) with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC): Whole body responses in the overall pt group and in pts with baseline brain metastases (BM)
| Autor: | Felip, E., Orlov, S., Park, K., Yu, C.-J., Tsai, C.-M., Nishio, M., Dols, M.C., McKeage, M., Su, W.-C., Mok, T.S.K., Scagliotti, G., Spigel, D.R., Passos, V.Q., Chen, V., Munarini, F., Shaw, A. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi416-vi416 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|